174 related articles for article (PubMed ID: 27760788)
1. Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
Chang WM; Lin YF; Su CY; Peng HY; Chang YC; Lai TC; Wu GH; Hsu YM; Chi LH; Hsiao JR; Chen CL; Chang JY; Shieh YS; Hsiao M; Shiah SG
Cancer Res; 2016 Dec; 76(24):7140-7150. PubMed ID: 27760788
[TBL] [Abstract][Full Text] [Related]
2. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
4. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
Kumar B; Yadav A; Lang J; Teknos TN; Kumar P
PLoS One; 2012; 7(5):e37601. PubMed ID: 22629428
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid Hormone-Like Hormone is a Poor Prognosis Marker of Head and Neck Cancer and Promotes Cell Growth via RUNX2 Regulation.
Chang WM; Lin YF; Su CY; Peng HY; Chang YC; Hsiao JR; Chen CL; Chang JY; Shieh YS; Hsiao M; Shiah SG
Sci Rep; 2017 Jan; 7():41131. PubMed ID: 28120940
[TBL] [Abstract][Full Text] [Related]
7. MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).
Zhang J; Wang Y; Chen X; Zhou Y; Jiang F; Chen J; Wang L; Zhang WF
Oncotarget; 2015 Apr; 6(10):7454-69. PubMed ID: 25762634
[TBL] [Abstract][Full Text] [Related]
8. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
9. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of IRS-1 promotes metastasis of head and neck squamous cell carcinoma.
Luo X; Fan S; Huang W; Zhai S; Ma Z; Li P; Sun SY; Wang X
Oncol Rep; 2012 Aug; 28(2):659-67. PubMed ID: 22664743
[TBL] [Abstract][Full Text] [Related]
11. Nicotine downregulates miR-375-3p via neurotrophic tyrosine receptor kinase 2 to enhance the malignant behaviors of laryngopharyngeal squamous epithelial cells.
Shen YJ; Ji MY; Huang Q; Hsueh CY; Du HD; Zhang M; Zhou L
Ecotoxicol Environ Saf; 2024 Apr; 274():116215. PubMed ID: 38489902
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
BMC Med; 2015 May; 13():108. PubMed ID: 25956054
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma.
Yata K; Beder LB; Tamagawa S; Hotomi M; Hirohashi Y; Grenman R; Yamanaka N
Int J Oncol; 2015 Oct; 47(4):1249-56. PubMed ID: 26323893
[TBL] [Abstract][Full Text] [Related]
15. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
17. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.
Fukumoto I; Kikkawa N; Matsushita R; Kato M; Kurozumi A; Nishikawa R; Goto Y; Koshizuka K; Hanazawa T; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2016 Feb; 61(2):109-18. PubMed ID: 26490187
[TBL] [Abstract][Full Text] [Related]
19. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J
Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385
[TBL] [Abstract][Full Text] [Related]
20. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
